Published in Am J Manag Care on August 01, 2009
Changes in drug use and out-of-pocket costs associated with Medicare Part D implementation: a systematic review. J Am Geriatr Soc (2010) 1.22
Digesting the doughnut hole. J Health Econ (2013) 1.00
The impact of Medicare Part D on out-of-pocket costs for prescription drugs, medication utilization, health resource utilization, and preference-based health utility. Health Serv Res (2011) 0.98
Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. J Clin Psychopharmacol (2012) 0.83
Medicare Part D plan generosity and medication use among dual-eligible nursing home residents. Med Care (2013) 0.79
Effects of Medicare Part D on drug affordability and use: Are seniors with prior high out-of-pocket drug spending affected more? Res Social Adm Pharm (2010) 0.78
Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA (2007) 6.51
Unintended consequences of caps on Medicare drug benefits. N Engl J Med (2006) 5.67
Cost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D. JAMA (2008) 4.74
The effect of the Medicare Part D prescription benefit on drug utilization and expenditures. Ann Intern Med (2008) 4.33
Effects of a limit on Medicaid drug-reimbursement benefits on the use of psychotropic agents and acute mental health services by patients with schizophrenia. N Engl J Med (1994) 3.50
The impact of Medicare Part D on prescription drug use by the elderly. Health Aff (Millwood) (2007) 3.33
Medicare beneficiaries' knowledge of Part D prescription drug program benefits and responses to drug costs. JAMA (2008) 2.31
Reporting of drug expenditures in the MCBS. Health Care Financ Rev (2003) 1.79
Medicare prescription drug coverage: consumer information and preferences. Proc Natl Acad Sci U S A (2006) 1.72
Status report on Medicare Part D enrollment in 2006: analysis of plan-specific market share and coverage. Health Aff (Millwood) (2006) 1.36
Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) (2007) 1.28
Employer drug benefit plans and spending on prescription drugs. JAMA (2002) 6.02
Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol (2003) 4.77
Differences in life expectancy due to race and educational differences are widening, and many may not catch up. Health Aff (Millwood) (2012) 4.36
Chip-NMR biosensor for detection and molecular analysis of cells. Nat Med (2008) 4.29
Prespecified falsification end points: can they validate true observational associations? JAMA (2013) 3.11
Forecasting the nursing home population. Med Care (2003) 3.11
Trends in the earnings of male and female health care professionals in the United States, 1987 to 2010. JAMA Intern Med (2013) 2.97
Sexually transmitted diseases among users of erectile dysfunction drugs: analysis of claims data. Ann Intern Med (2010) 2.93
Why physicians work when sick. Arch Intern Med (2012) 2.65
On average, physicians spend nearly 11 percent of their 40-year careers with an open, unresolved malpractice claim. Health Aff (Millwood) (2013) 2.26
An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancer. Health Aff (Millwood) (2012) 2.16
The European Working Time Directive: an uncontrolled experiment in medical care and education. JAMA (2013) 2.10
Heterogeneity in action: the role of passive personalization in comparative effectiveness research. Health Econ (2013) 2.04
Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff (Millwood) (2013) 2.03
Aging in America in the twenty-first century: demographic forecasts from the MacArthur Foundation Research Network on an Aging Society. Milbank Q (2009) 1.89
Are the young becoming more disabled? Health Aff (Millwood) (2004) 1.88
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumonia. J Gen Intern Med (2012) 1.83
Out-of-pocket medication costs and use of medications and health care services among children with asthma. JAMA (2012) 1.83
The health and cost consequences of obesity among the future elderly. Health Aff (Millwood) (2005) 1.79
Hospital spending and inpatient mortality: evidence from California: an observational study. Ann Intern Med (2011) 1.79
Growing Internet use may help explain the rise in prescription drug abuse in the United States. Health Aff (Millwood) (2011) 1.71
Impact of specialty drugs on the use of other medical services. Am J Manag Care (2008) 1.51
Three large-scale changes to the Medicare program could curb its costs but also reduce enrollment. Health Aff (Millwood) (2013) 1.50
Competition among hospitals. Rand J Econ (2003) 1.49
U.S. pharmaceutical policy in a global marketplace. Health Aff (Millwood) (2008) 1.47
Cost sharing and the initiation of drug therapy for the chronically ill. Arch Intern Med (2009) 1.41
Drug licenses: a new model for pharmaceutical pricing. Health Aff (Millwood) (2008) 1.39
Patients value metastatic cancer therapy more highly than is typically shown through traditional estimates. Health Aff (Millwood) (2012) 1.38
Pharmacy benefit caps and the chronically ill. Health Aff (Millwood) (2007) 1.28
Cost sharing, family health care burden, and the use of specialty drugs for rheumatoid arthritis. Health Serv Res (2010) 1.27
Disability and health care spending among medicare beneficiaries. Health Aff (Millwood) (2005) 1.26
The value of specialty oncology drugs. Health Serv Res (2009) 1.24
The lifetime burden of chronic disease among the elderly. Health Aff (Millwood) (2005) 1.23
Hospital value-based purchasing. J Hosp Med (2013) 1.21
HIV care providers emphasize the importance of the Ryan White Program for access to and quality of care. Health Aff (Millwood) (2014) 1.21
An economic evaluation of the war on cancer. J Health Econ (2010) 1.13
The promise of health care cost containment. Health Aff (Millwood) (2007) 1.13
The effect of regulation on pharmaceutical revenues: experience in nineteen countries. Health Aff (Millwood) (2008) 1.13
Undiagnosed disease, especially diabetes, casts doubt on some of reported health 'advantage' of recent Mexican immigrants. Health Aff (Millwood) (2012) 1.08
Exenatide therapy and the risk of pancreatitis and pancreatic cancer in a privately insured population. Diabetes Technol Ther (2012) 1.07
Does the profit motive make Jack nimble? Ownership form and the evolution of the US hospital industry. Health Econ (2006) 1.05
Outcomes of Basic Versus Advanced Life Support for Out-of-Hospital Medical Emergencies. Ann Intern Med (2015) 1.02
The large social value resulting from use of statins warrants steps to improve adherence and broaden treatment. Health Aff (Millwood) (2012) 1.01
Digesting the doughnut hole. J Health Econ (2013) 1.00
Medicare Part D: a successful start with room for improvement. JAMA (2008) 0.99
The impact of comparative effectiveness research on health and health care spending. J Health Econ (2011) 0.98
The Disability burden of COPD. COPD (2012) 0.97
Economics of nerve block pain management after anterior cruciate ligament reconstruction: potential hospital cost savings via associated postanesthesia care unit bypass and same-day discharge. Anesthesiology (2004) 0.97
Impact of oral nutritional supplementation on hospital outcomes. Am J Manag Care (2013) 0.97
Trends in the earnings of health care professionals in the United States, 1987-2010. JAMA (2012) 0.97
How costly is hospital quality? A revealed-preference approach. J Ind Econ (2011) 0.96
Hormone replacement therapy and cardiovascular health in the United States. Med Care (2009) 0.96
Identifying potential health care innovations for the future elderly. Health Aff (Millwood) (2005) 0.96
The potential impact of comparative effectiveness research on U.S. health care expenditures. Demography (2010) 0.93
Spending and mortality in US acute care hospitals. Am J Manag Care (2013) 0.93
The prospect of a generation free of HIV may be within reach if the right policy decisions are made. Health Aff (Millwood) (2014) 0.92
The pragmatist's guide to comparative effectiveness research. J Econ Perspect (2011) 0.92
Physician prescribing behavior and its impact on patient-level outcomes. Am J Manag Care (2011) 0.91
Predicting new diagnoses of HIV infection using internet search engine data. Clin Infect Dis (2013) 0.91
Nearly 60,000 uninsured and low-income people with HIV/AIDS live in states that are not expanding Medicaid. Health Aff (Millwood) (2014) 0.90
The changing face of pharmacy benefit design. Health Aff (Millwood) (2004) 0.90
Data-driven decision-making tools to improve public resource allocation for care and prevention of HIV/AIDS. Health Aff (Millwood) (2014) 0.90
Technological advances in cancer and future spending by the elderly. Health Aff (Millwood) (2005) 0.90
Guidance for structuring team-based incentives in healthcare. Am J Manag Care (2013) 0.89
Defense costs of medical malpractice claims. N Engl J Med (2012) 0.89
Medicaid cost control measures aimed at second-generation antipsychotics led to less use of all antipsychotics. Health Aff (Millwood) (2011) 0.89
Reducing Diagnostic Errors--Why Now? N Engl J Med (2015) 0.89
Disability forecasts and future Medicare costs. Front Health Policy Res (2004) 0.88
Hospital prices and market structure in the hospital and insurance industries. Health Econ Policy Law (2010) 0.88
The economics of intense exercise. J Health Econ (2010) 0.87
Hospital costs and inpatient mortality among children undergoing surgery for congenital heart disease. Health Serv Res (2013) 0.86
Racial and ethnic disparities in hospital care resulting from air pollution in excess of federal standards. Soc Sci Med (2011) 0.86
Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD. Curr Med Res Opin (2012) 0.85
Coverage and preventive screening. Health Serv Res (2010) 0.85
Early HIV treatment in the United States prevented nearly 13,500 infections per year during 1996-2009. Health Aff (Millwood) (2014) 0.85
Association between the birth of twins and parental divorce. Obstet Gynecol (2011) 0.83
Diabetes management for low-income patients in Los Angeles: two strategies improved disease control in the short term. Health Aff (Millwood) (2012) 0.83
The value of medical and pharmaceutical interventions for reducing obesity. J Health Econ (2012) 0.82
Effect of hospital use of oral nutritional supplementation on length of stay, hospital cost, and 30-day readmissions among Medicare patients with COPD. Chest (2015) 0.81
Prescription medication abuse and illegitimate internet-based pharmacies. Ann Intern Med (2011) 0.81
Postinterview communication between military residency applicants and training programs. Mil Med (2012) 0.81
Measuring the value of better diabetes management. Am J Manag Care (2013) 0.81
Is the Food and Drug Administration safe and effective? J Econ Perspect (2008) 0.81
A socioeconomic profile of older adults with HIV. J Health Care Poor Underserved (2005) 0.80
Beta-blocker compliance, mortality, and reinfarction: validation of clinical trial association using insurer claims data. Am J Med Qual (2009) 0.80
Polymerase translocation with respect to single-stranded nucleic acid: looping or wrapping of primer around a poly(A) polymerase. Structure (2009) 0.80
Early HIV treatment led to life expectancy gains valued at $80 billion for people infected in 1996-2009. Health Aff (Millwood) (2014) 0.80
Can an acute pain service be cost-effective? Anesth Analg (2010) 0.79
How do households choose their employer-based health insurance? Inquiry (2007) 0.79
Structure-based design of Aurora A & B inhibitors. J Comput Aided Mol Des (2008) 0.79
Did Medicare Part D reduce disparities? Am J Manag Care (2015) 0.79